Find a Tender
complete
Official procurement procedure
NP49425 Generic and Biosimilar Transition Medicines
Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS): "NP49425 Generic and Biosimilar Transition Medicines". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
Not availableNo published reports
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 0 active published awards; 0 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published30 Mar 2026, 14:46 BST | Last source update30 Mar 2026, 14:46 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-0581ea | ||
What is being bought
No description published
What changed
From the official release history
- Status changed to published status
30 Mar 2026, 14:46 BST - Official notice release published
30 Mar 2026, 14:46 BST - Status changed to complete
19 Dec 2025, 16:55 GMT - Official notice release published
19 Dec 2025, 16:55 GMT - tender value changed
4 Sept 2025, 17:01 BST - Status changed to published status
4 Sept 2025, 17:01 BST - Official notice release published
4 Sept 2025, 17:01 BST - Submission deadline changed to published date
4 Sept 2025, 17:01 BST - Published value updated to £234,969,011
21 Aug 2025, 10:55 BST - Status changed to active
21 Aug 2025, 10:55 BST - Official notice release published
21 Aug 2025, 10:55 BST - Submission deadline changed to 22 Sept 2025, 12:00 BST
21 Aug 2025, 10:55 BST - Published value updated to £131,244,104
5 Aug 2025, 16:26 BST - Status changed to planned
5 Aug 2025, 16:26 BST - Official notice release published
5 Aug 2025, 16:26 BST - Buyer information updated
5 Aug 2025, 16:26 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedSupply of generic cand biosimilar transition medicines to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
30 Mar 2026, 14:46 BST - Award active
Not published · Not published - Contract active
Signed 18 Dec 2025, 00:00 GMT · £64,103,740
Commercial outcome and competition
Awards AOP Orphan Ltd, Accord Healthcare Ltd, Amarox Limited, Amgen Ltd, Brown and Burk, Celix Pharma Ltd., Celltrion Healthcare United Kingdom Limited, Chiesi Ltd, Dr Falk Pharma UK Ltd, Ferring Pharmaceuticals Limited, Fresenius Kabi, Gedeon Richter UK Ltd, Glenmark Pharmaceuticals Europe Ltd, Janssen-Cilag Ltd, Lupin Healthcare UK Ltd Not published · Not published · active |
Contracts Contract £64,103,740 · signed 18 Dec 2025, 00:00 GMT · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contracting authority GB-FTS-115937Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published